|
KATNAL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.73849999999854E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.963500E-03 |
| Normal-vs-Stage2 |
4.292200E-02 |
| Normal-vs-Stage3 |
6.354000E-02 |
| Normal-vs-Stage4 |
2.648200E-01 |
| Stage1-vs-Stage2 |
4.012000E-01 |
| Stage1-vs-Stage3 |
9.102600E-01 |
| Stage1-vs-Stage4 |
6.478600E-01 |
| Stage2-vs-Stage3 |
4.749400E-01 |
| Stage2-vs-Stage4 |
8.936800E-01 |
| Stage3-vs-Stage4 |
6.931800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.53089999999879E-05 |
| Normal-vs-AfricanAmerican |
4.037900E-02 |
| Normal-vs-Asian |
7.261800E-01 |
| Caucasian-vs-AfricanAmerican |
5.408000E-01 |
| Caucasian-vs-Asian |
2.369200E-01 |
| AfricanAmerican-vs-Asian |
3.140000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.562900E-03 |
| Normal-vs-Female |
7.56130000000299E-05 |
| Male-vs-Female |
1.710010E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.559500E-02 |
| Normal-vs-Extreme_Weight |
3.095000E-01 |
| Normal-vs-Obese |
1.039240E-03 |
| Normal-vs-Extreme_Obese |
7.756000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.515200E-01 |
| Normal_Weight-vs-Obese |
2.799000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.030400E-01 |
| Extreme_Weight-vs-Obese |
3.861900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.131200E-01 |
| Obese-vs-Extreme_Obese |
2.510400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.007420E-01 |
| Normal-vs-Age(41-60Yrs) |
1.64541999999601E-05 |
| Normal-vs-Age(61-80Yrs) |
4.086500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.274800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.571200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.823400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.173200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.838400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.160800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.973200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.411100E-04 |
| Normal-VS-Type2 PRCC |
6.434300E-02 |
| Normal-VS-KIRP CIMP |
6.533500E-02 |
| Normal-VS-Unclassified PRCC |
5.440200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.210600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.537600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.341700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.917800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.722440E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.364000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.664200E-01 |
| Normal-vs-N1 |
6.623200E-03 |
| Normal-vs-N2 |
2.024400E-01 |
| N0-vs-N1 |
5.795500E-02 |
| N0-vs-N2 |
8.362200E-01 |
| N1-vs-N2 |
4.950400E-01 |
|
|
